|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating activities | ||||
| Profit/(loss) before income tax | ||||
| Adjustments for: | ||||
| Allowance for expected credit losses on trade receivables | ||||
| Impairment loss on intangible assets | ||||
| Provision for allowance for expected credit losses - trade receivables | ||||
| Provision for allowance for expected credit losses - other receivables | ||||
| Provision for allowance for expected credit losses - loan receivables | ||||
| Non-cash revenue received in shares | ||||
| Acquisition of financial assets in shares | ||||
| Reversal on impairment allowance of trade receivables | ||||
| Reversal on impairment allowance of other receivables | ||||
| Reversal on impairment allowance of loan receivables | ||||
| Loss on investment | ||||
| Fair value loss on financial assets, at fair value through profit or loss | ||||
| Share-based compensation awards | ||||
| Share option expenses | ||||
| Director fees paid in shares | ||||
| Share based payment – consultancy fees | ||||
| Fair value loss on derivative liabilities through profit and loss | ||||
| Write-off on intangible assets | ||||
| Depreciation of property and equipment | ||||
| Depreciation of right-of-use assets | ||||
| Amortisation of intangible assets | ||||
| Change in working capital, net of effects from acquisition and disposal of subsidiaries | ||||
| Bad debt written off | ||||
| Issuance of warrant liabilities | ||||
| Loss on dissolve of subsidiaries | ||||
| Change in fair value of warrant liabilities | ||||
| Interest expense | ||||
| Interest income | ||||
| Operating cash flows before movements in working capital | ||||
| Trade and other receivables | ||||
| Inventories | ||||
| Loan receivables | ||||
| Trade and other payables | ||||
| Cash generated from/(used in) operations | ||||
| Income tax (paid)/refund | ||||
| Net cash generated from/(used in) operating activities | ||||
| Investing activities | ||||
| Acquisition of property and equipment | ||||
| Acquisition of intangible assets | ||||
| Interest received | ||||
| Acquisition of financial assets, at fair value through other comprehensive income | ||||
| Proceeds from disposal of financial assets, at fair value through other comprehensive income | ||||
| Proceeds from disposal of subsidiaries, net of cash and cash equivalents disposed of | ||||
| Proceeds from disposal of financial assets, at fair value through profit and loss | ||||
| Net cash used in investing activities | ||||
| Financing activities | ||||
| Proceeds from issuance of ordinary shares | ||||
| Proceeds from lease liabilities | ||||
| Repayment of other borrowings | ||||
| Repayment of bank borrowings | ||||
| Interest paid – lease obligation | ||||
| Interest paid | ||||
| Proceeds from initial public offering, net of transaction cost | ||||
| Payment for initial public offering expense | ||||
| Repayment of operating leases | ||||
| Payment for lease liabilities | ||||
| Repayment of advances made from related parties | ||||
| Proceeds from issuance of convertible notes | ||||
| Dividend paid | ||||
| Net cash generated from financing activities | ||||
| Net increase/(decrease) in cash and cash equivalents | ||||
| Foreign exchange effect | ||||
| Cash and bank balances at beginning of year | ||||
| Cash and bank balances at end of year | ||||
Loading...